Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS Mutation (NEXIRI)
This study has been completed.
Sponsor:
Centre Val d'Aurelle - Paul Lamarque
Collaborator:
Bayer
Information provided by (Responsible Party):
Centre Val d'Aurelle - Paul Lamarque
ClinicalTrials.gov Identifier:
NCT00989469
First received: October 2, 2009
Last updated: February 9, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2012 |
| Primary Completion Date: | February 2011 (Final data collection date for primary outcome measure) |